Gene expression signatures of neuroendocrine prostate cancer and primary small cell prostatic carcinoma

Abstract Background Neuroendocrine prostate cancer (NEPC) may be rising in prevalence as patients with advanced prostate cancer potentially develop resistance to contemporary anti-androgen treatment through a neuroendocrine phenotype. While prior studies comparing NEPC and prostatic adenocarcinoma h...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Harrison K. Tsai, Jonathan Lehrer, Mohammed Alshalalfa, Nicholas Erho, Elai Davicioni, Tamara L. Lotan
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: BMC 2017-11-01
Seri Bilgileri:BMC Cancer
Konular:
Neuroendocrine prostate cancer
Small cell carcinoma
Mixed prostatic adenocarcinoma
FFPE
Gene signature
Meta-analysis
Online Erişim:http://link.springer.com/article/10.1186/s12885-017-3729-z
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller